GET an adme quote
Connect your science
Connect with us

Start your own journey to clinic

Please provide us with a few details so that we can match you with the right expert in your field.

*Required

Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at webenquiries@conceptlifesciences.com

Featured capabilities

The future of AI in Drug Discovery

Revolutionize your Hit ID with Biopals

Written by

Introducing BioPALS —an innovative, lean, and versatile HIT identification platform combining AI-powered virtual screening with cutting-edge biophysical technologies.

BioPALS enables the rapid identification and comprehensive characterization of hits with full binding kinetics, affinities and topologies.

When compared to traditional HTS campaigns, BioPALS typically is:

  • Screening billions more molecules
  • 10 times cheaper
  • 3x faster

Want to know more?

Explore what BioPALS can do for you in our video with Dr Thomas Pesnot:​​​ BioPals on Vimeo

You may also download our poster showcasing our BioPALS platform in detail.

‍

‍

Upcoming Events Schedule
Search
Clear
Country
Clear
Select
Month
Clear
Select
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
Showing 0 of 100
Event
British Society for Immunology
Belfast
,
United Kingdom
Dec 4, 2024
December
No results found.
There are no results with this criteria. Try changing your search.
News and Expert Knowledge
Search
Clear
Type
Clear
Select
Relevant Service Line
Clear
Select
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
Showing 0 of 100
News
Concept Life Sciences Welcomes Chris Yarnold as Director Of Medicinal Chemistry

by:
Service Line:
News
Limerston Capital Backed Concept Life Sciences Announces Acquisition Of Charnwood Discovery

UK-based drug discovery, development and manufacturing organisation, Concept Life Sciences (CLS), backed by mid-market private equity investment firm Limerston Capital, has completed the acquisition of Charnwood Discovery.

by:
Service Line:
Featured capabilities
Tumor Cell killing Assay: How To Choose The Right One

A guide to choosing the right tumour cell killing assay

by:
Service Line:
Biology
Featured capabilities
The future of AI in Drug Discovery

Revolutionize your Hit ID with Biopals

by:
Service Line:
Chemistry
Featured capabilities
Precision ADME & DMPK insights for Drug Discovery

Accelerate your design, make, test cycle with leading in vitro ADME & in vivo DMPK

by:
Service Line:
ADME & DMPK
Featured capabilities
Understanding Thyroxin Modulation

In vitro assays for your chemical or agrochemical regulatory submission

by:
Service Line:
Toxicology
Featured capabilities
Call Off Contracts At Concept

Balancing Flexibility With Control

by:
Service Line:
ADME & DMPK
News
Our Concept Commends 2023 Winners

Celebrating excellence in client satisfaction, innovation and support

by:
Service Line:
Expert Knowledge
What is AI and why is important in drug discovery?

by:
Tom Pesnot
Service Line:
Chemistry
Expert Knowledge
What's new in AI for Drug Discovery and Development?

by:
Tom Pesnot
Service Line:
Chemistry
No results found.
There are no results with this criteria. Try changing your search.